MedTrace Logo

A Study in Adult Subjects With Chronic Hepatitis B Infection to Support the Development of Immunological Assays

NCT01098006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2020-02-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop and characterize immunological assays on blood samples.

Conditions

  • Immunologic Tests

Interventions

OTHER

Blood withdrawal

A single blood sample was to be taken from all subjects at the study visit. No study-related treatment was given to the study participants.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-29
Primary Completion
2012-02-20
Completion
2012-02-20

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01098006 on ClinicalTrials.gov